These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 1906425

  • 1. Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatment.
    Mulder JW, Krijnen P, Coutinho RA, Bakker M, Goudsmit J, Lange JM.
    Genitourin Med; 1991 Jun; 67(3):188-93. PubMed ID: 1906425
    [Abstract] [Full Text] [Related]

  • 2. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA, Bacchetti P, Kolokathis A, Chaisson RE, Szabo S, Polsky B, Valainis GT, Mildvan D, Abrams D, Wilber J.
    BMJ; 1991 Jan 12; 302(6768):73-8. PubMed ID: 1671651
    [Abstract] [Full Text] [Related]

  • 3. Serum p24 antigen levels in untreated and zidovudine-treated HIV-1 infected subjects.
    Mulder JW, Lange JM, de Wolf F, Houweling JT, Bakker M, Coutinho RA, Goudsmit J.
    Neth J Med; 1990 Aug 12; 37(1-2):4-10. PubMed ID: 2120599
    [Abstract] [Full Text] [Related]

  • 4. Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine.
    Jacobson MA, Abrams DI, Volberding PA, Bacchetti P, Wilber J, Chaisson RE, Crowe S, Howard W, Moss A.
    J Infect Dis; 1989 Jun 12; 159(6):1029-36. PubMed ID: 2566637
    [Abstract] [Full Text] [Related]

  • 5. Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects.
    Mulder JW, de Wolf F, Goudsmit J, Cload PA, Coutinho RA, Fiddian AP, Schellekens PT, van der Noordaa J, Lange JM.
    Antiviral Res; 1990 Mar 12; 13(3):127-38. PubMed ID: 1972321
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy.
    Siller L, Martin NL, Kostuchenko P, Beckett L, Rautonen J, Cheng SC, Wara DW.
    AIDS; 1993 Mar 12; 7(3):369-73. PubMed ID: 8097095
    [Abstract] [Full Text] [Related]

  • 7. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection.
    Lifson AR, Hessol NA, Buchbinder SP, O'Malley PM, Barnhart L, Segal M, Katz MH, Holmberg SD.
    Lancet; 1992 Jun 13; 339(8807):1436-40. PubMed ID: 1351128
    [Abstract] [Full Text] [Related]

  • 8. Surrogate markers for AIDS treatment.
    Jacobson M.
    Nurs Times; 1992 Jun 13; 87(22):49. PubMed ID: 1675013
    [No Abstract] [Full Text] [Related]

  • 9. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV.
    N Engl J Med; 1990 Jan 18; 322(3):166-72. PubMed ID: 1967191
    [Abstract] [Full Text] [Related]

  • 10. Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine.
    Crocchiolo PR, Lizioli A, Arcidiacono I, Cantaluppi P, Filippi C, Sobatti D, Bedarida G, D'Agostino F, Cambie G, Nardella ML.
    Boll Ist Sieroter Milan; 1990 Jun 18; 69(2):423-30. PubMed ID: 1983798
    [Abstract] [Full Text] [Related]

  • 11. Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression.
    Molina JM, Ferchal F, Chevret S, Barateau V, Poirot C, Morinet F, Modai J.
    AIDS; 1994 Jan 18; 8(1):27-33. PubMed ID: 7912084
    [Abstract] [Full Text] [Related]

  • 12. Neopterin and beta-2 microglobulin levels in asymptomatic HIV infection: the predictive value of combining markers.
    Harrison NA, Skidmore SJ.
    J Med Virol; 1990 Oct 18; 32(2):128-33. PubMed ID: 2126281
    [Abstract] [Full Text] [Related]

  • 13. Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS.
    Jurriaans S, Weverling GJ, Goudsmit J, Boogaard J, Brok M, Van Strijp D, Lange J, Koot M, Van Gemen B.
    AIDS Res Hum Retroviruses; 1995 Apr 18; 11(4):473-9. PubMed ID: 7632462
    [Abstract] [Full Text] [Related]

  • 14. Immune activation markers and AIDS prognosis.
    Osmond DH, Shiboski S, Bacchetti P, Winger EE, Moss AR.
    AIDS; 1991 May 18; 5(5):505-11. PubMed ID: 1677808
    [Abstract] [Full Text] [Related]

  • 15. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA, Lagakos SW, Koch MA, Pettinelli C, Myers MW, Booth DK, Balfour HH, Reichman RC, Bartlett JA, Hirsch MS.
    N Engl J Med; 1990 Apr 05; 322(14):941-9. PubMed ID: 1969115
    [Abstract] [Full Text] [Related]

  • 16. Effect of azidothymidine (AZT) on HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD8, soluble interleukin-2 receptor and tumor necrosis factor alpha levels in patients with AIDS-related complex or AIDS.
    Reddy MM, McKinley G, Englard A, Grieco MH.
    Int J Immunopharmacol; 1990 Apr 05; 12(7):737-41. PubMed ID: 2127261
    [Abstract] [Full Text] [Related]

  • 17. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).
    Mulder JW, Cooper DA, Mathiesen L, Sandström E, Clumeck N, Gatell JM, French M, Donovan B, Gray F, Yeo JM.
    AIDS; 1994 Mar 05; 8(3):313-21. PubMed ID: 7913326
    [Abstract] [Full Text] [Related]

  • 18. Markers for progression to acquired immune deficiency syndrome and zidovudine treatment of asymptomatic patients.
    Lange JM, de Wolf F, Mulder JW, Coutinho RA, van der Noordaa J, Goudsmit J.
    J Infect; 1989 Jan 05; 18 Suppl 1():85-91. PubMed ID: 2492586
    [Abstract] [Full Text] [Related]

  • 19. Serum beta 2-microglobulin in intravenous drug users and its correlation with human immunodeficiency virus infection.
    Chironna M, Fanelli M, Potenza D, Serio G, Quarto M.
    Int J Clin Lab Res; 1994 Jan 05; 24(2):90-3. PubMed ID: 7919434
    [Abstract] [Full Text] [Related]

  • 20. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.
    Pedersen C, Cooper DA, Brun-Vézinet F, Doherty R, Skinhøj P, Pérol Y, Lüthy R, Leibowitch J, Habermehl KO, Varnier OE.
    AIDS; 1992 Aug 05; 6(8):821-5. PubMed ID: 1418778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.